News & Press

News & Press

Toronto, Ontario – April 20, 2021– Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the listing of certain RHO Phyto products with the Ontario, Manitoba, Saskatchewan and New Brunswick provincial retailers (the “Initial Listing”)....

29 June, 2021 /

Toronto, Ontario – April 20, 2021– Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the listing of certain RHO Phyto products with the Ontario, Manitoba, Saskatchewan and New Brunswick provincial retailers (the “Initial Listing”)....

13 May, 2021 /

Toronto, Ontario – April 20, 2021– Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the listing of certain RHO Phyto products with the Ontario, Manitoba, Saskatchewan and New Brunswick provincial retailers (the “Initial Listing”)....

06 May, 2021 /

Toronto, Ontario – April 20, 2021– Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the listing of certain RHO Phyto products with the Ontario, Manitoba, Saskatchewan and New Brunswick provincial retailers (the “Initial Listing”)....

20 April, 2021 /

Avicanna was launched by a group of scientists, clinicians and biotech executives in Toronto four and a half years ago. Its cofounder, Aras Azadian, an entrepreneur with experience in both the financial and biotech worlds, had a purely medicinal cannabis mission: to provide patients with advanced formulations of cannabinoids backed by scientific rigor and clinical evidence. They were the only cannabis company to be admitted into Johnson and Johnson’s prestigious research incubator, JLabs, in the MaRS Discovery District, and have been collaborating...

28 January, 2021 /

TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) – Avicanna Inc. has updated and amended its collaboration with Dr. Jibran Khokhar, Assistant Professor at the University of Guelph, and initiated prioritized pre-clinical studies on the RHO Phyto formulations that are commercialized in Canada and Colombia. Additionally, the Company provides an update on research projects with the University of Toronto and Thompson Rivers University as well as a change to its management team....

21 January, 2021 /

TORONTO, Sept. 21, 2020 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that its advanced RHO Phyto Rapid Act Sprays are now officially available nationwide in Canada on the Medical Cannabis by Shoppers (“Shoppers”) portal, as well as through the Medical Cannabis Real-World Evidence Study at the University Health Network. Avicanna’s RHO Phyto product line ...

21 September, 2020 /

Avicanna was launched by a group of scientists, clinicians and biotech executives in Toronto four and a half years ago. Its cofounder, Aras Azadian, an entrepreneur with experience in both the financial and biotech worlds, had a purely medicinal cannabis mission: to provide patients with advanced formulations of cannabinoids backed by scientific rigor and clinical evidence. They were the only cannabis company to be admitted into Johnson and Johnson’s prestigious research incubator, JLabs, in the MaRS Discovery District, and have been collaborating...

15 September, 2020 /

TORONTO, August 12, 2020 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that its advanced RHO Phyto™ Micro Drop oils are now officially available nationwide in Canada on the Medical Cannabis by Shoppers™ (“Shoppers”) platform as well as through the Medical Cannabis Real-World Evidence study (“MC-RWE study”) at the University Health Network (“UHN”) as announced by the Company on July 15, 2020....

12 August, 2020 /

Toronto, Ontario – July 15, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that its Rho Phyto™ product line of advanced medical cannabis products will be the subject of a Medical Cannabis Real-World Evidence study (“MC-RWE Study”) led by Dr. Hance Clarke of the University Health Network (“UHN”) in Toronto, Canada. The Rho Phyto products were developed in accordance with the recent Health Canada Cannabis 2.0 regulations for that allow for more advanced, higher quality, medical cannabis product offerings. These products have been tested for prolonged stability, enhanced absorption, controlled delivery and other properties in collaboration with Christine Allen’s research group at the Leslie Dan Faculty of Pharmacy, University of Toronto....

15 July, 2020 /

Join our newsletter

Get the first look at new products, educational materials, and more.

RHO PHYTO

info@rhophyto.com

www.rhophyto.com

Are you 19 or older?

You must verify that you are 19 years of age or older
to enter this site.